Cell-derived matrices for tissue engineering and regenerative medicine applications

Biomater Sci. 2015 Jan;3(1):12-24. doi: 10.1039/C4BM00246F.

Abstract

The development and application of decellularized extracellular matrices (ECM) has grown rapidly in the fields of cell biology, tissue engineering and regenerative medicine in recent years. Similar to decellularized tissues and whole organs, cell-derived matrices (CDMs) represent bioactive, biocompatible materials consisting of a complex assembly of fibrillar proteins, matrix macromolecules and associated growth factors that often recapitulate, at least to some extent, the composition and organization of native ECM microenvironments. The unique ability to engineer CDMs de novo based on cell source and culture methods makes them an attractive alternative to conventional allogeneic and xenogeneic tissue-derived matrices that are currently harvested from cadaveric sources, suffer from inherent heterogeneity, and have limited ability for customization. Although CDMs have been investigated for a number of biomedical applications, including adhesive cell culture substrates, synthetic scaffold coatings, and tissue engineered products, such as heart valves and vascular grafts, the state of the field is still at a relatively nascent stage of development. In this review, we provide an overview of the various applications of CDM and discuss successes to date, current limitations and future directions.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Biocompatible Materials / chemistry*
  • Blood Vessel Prosthesis / psychology*
  • Extracellular Matrix / chemistry
  • Heart Valves / chemistry
  • Heart Valves / metabolism
  • Heart Valves / physiology*
  • Humans
  • Regenerative Medicine / methods*
  • Tissue Engineering / methods*
  • Tissue Scaffolds / chemistry*

Substances

  • Biocompatible Materials